Cholangiocarcinoma

-
Cholangiocarcinoma is a rare cancer found in the tissue of the bile ducts, occurring in approximately two out of 100,000 people. Men and women are equally affected and most cases occur in people over age 65. The bile duct is a small tube that connects the liver and gallbladder to the small intestine. The ducts carry bile  the liquid that helps break down fat in food during digestion  out of the liver.
Tumors can develop anywhere on the bile ducts and are typically slow growing. However, by the time a diagnosis usually is made, many of the tumors are too advanced to be surgically removed. Other conditions such as primary sclerosing cholangitis, bile duct cysts and chronic biliary irritation, are associated with an increased risk of cholangiocarcinoma.
Signs & Symptoms:
Cholangiocarcinoma is a rare cancer found in the tissue of the bile ducts. Tumors produce symptoms by blocking the bile ducts. Common symptoms may include:
- Clay colored stools
- Jaundice, which is a yellowing of the skin and eyes
- Itching
- Abdominal pain that may extend to the back
- Loss of appetite
- Unexplained weight loss
- Fever
- Chills

Diagnosis:
Your doctor will first ask about your medical history and perform a physical examination. In addition, he or she may order the following tests:
Computed Tomography (CT) Scan: An X-ray that uses a computer to provide an image of the inside of the abdomen.
Magnetic Resonance Imaging (MRI) Scan: This test uses magnetic waves to create an image.
Ultrasound: This test uses high-frequency sound waves that echo off the body to create a picture.
Endoscopic Retrograde Cholangiopancreatography (ERCP): During an ERCP, a flexible tube is inserted down the throat and into the stomach and small intestine. By injecting dye into the drainage tube of the pancreas, your doctor can see the area more clearly.
Endoscopic Ultrasound (EUS): EUS involves passing a thin, flexible tube called an endoscope through the mouth or the anus to exam the lining and walls of the upper and lower gastrointestinal tract and nearby organs such as the pancreas and gall bladder. The endoscope is equipped with a small ultrasound transducer that produces sounds waves that create a viewable image of the digestive track. When combined with fine needle aspiration, EUS becomes a state-of-the-art, minimally invasive alternative to exploratory surgery to remove tissue samples from abdominal and other organs. It also may be used to determine the cause of symptoms such as abdominal pain, to evaluate a growth, to diagnose diseases of the pancreas, bile duct and gall bladder when other tests are inconclusive and to determine the extent of certain cancers of the lungs or digestive tract.
Percutaneous Transhepatic Cholangiography (PTC): By injecting dye into the bile duct through a thin needle inserted into the liver, blockages can be seen on X-ray.
Bile Duct Biopsy and Fine Needle Aspiration: A tiny sample of the bile duct fluid or tissue is removed and examined under a microscope.
Treatment:
Surgery and radiation therapy are the two most common treatments for cholangiocarcinoma.
Surgery
If the cancer is small and has not spread beyond the bile duct, your doctor may remove the whole bile duct and make a new duct by connecting the duct openings in the liver to the intestine. Lymph nodes also will be removed and examined under the microscope to see if they contain cancer. If the cancer has spread and cannot be removed, your doctor may perform surgery to relieve symptoms.
If the cancer is blocking the small intestine and bile builds up in the gallbladder, surgery may be required. During this operation, called a biliary bypass, your doctor will cut the gallbladder or bile duct and sew it to the small intestine. After complete removal of the tumor, 30 percent to 40 percent of patients survive for at least five years, with the possibility of being completely cured. If the tumor cannot be completely removed, it generally is not possible to cure the patient. In these cases, if you are not a candidate for surgery and have an obstruction, percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP) can be used to place plastic or metal stents, which help to relieve obstructions.
Radiation Therapy
Radiation therapy is the use of high-energy X-rays to kill cancer cells and shrink tumors. There are two main types of radiation therapy:
External-Beam Radiation Therapy: Radiation comes from a machine outside the body.
Internal Radiation Therapy: Materials that produce radiation, called radioisotopes, are put into the area where the cancer cells are found through thin plastic tubes.
Experimental Therapy
There are a couple types of therapy that are currently being studied in clinical trials for the treatment of cholangiocarcinoma, including:
Chemotherapy: Uses drugs to kill cancer cells
Biological Therapy: Uses the body's immune system to fight cancer.

Photodynamic Therapy: Uses a specific type of light and photosensitizing agent to kill cancer cells.

Comments

Post a Comment

Popular posts from this blog

Pleural Effusion

-
Image
Pleural effusion , sometimes referred to as “water on the lungs,” is the build-up of excess  fluid  between the layers of the pleura  outside the lungs. The  pleura  are thin membranes that line the lungs and the inside of the chest cavity and act to lubricate and facilitate breathing. Differential Diagnosis Exudative malignancy, infections, connective tissue disease, pulmonary embolism, hemothorax, pancreatitis, chylothorax Trabsydatuve HF, hypoalbuminemia (GI losing enteropathy, cirrhosis, nephrotic syndrome, malnutrition), SVC obstruction, hepatohydrothorax, urinothorax, atelectasis, trapped lung, peritoneal dialysis, hypothyroidism, pulmonary embolism Note: pulmonary embolism, malignancy, and sar coidosis can present as either exudative or transudative effusions. HF following diuresis may become ‘‘pseudo exudative’’ (check albumin gradient) Clinical Features History dyspnea, cough, hemoptysis, chest pain, weight loss, fever, trauma, occup...
Read more

FNAC of Salivary Gland Tumors

-
Image
Fine Needle Aspiration Cytology (FNAC) of Salivary Gland Tumors Introduction: Salivary gland neoplasms though relatively uncommon are by no means rare, accounting for 3 % of all head and neck tumors. Distribution wise 80% of the tumors occur in parotid gland, 15% in submandibular gland and less than 1% in sublingual glands. The World Health Organization (WHO) has classified the tumors of salivary gland as primary or secondary, malignant or benign and by the tissue of origin. The five broad – categories of salivary gland tumors are: Malignant tumors: e.g. Mucoepidermoid Carcinoma, Acinic cell Carcinoma and Adenoid Cystic Carcinoma, Benign tumors: e.g. Pleomorphic Adenoma, Warthin’s tumor, Myoepithelioma, Soft Tissue tumors: e.g. Hemangioma, Hematolymphoid tumors: e.g. Hodgkin’s Lymphoma & Secondary tumors. Of the malignant tumors Mucoepidermoid Carcinoma is the most common neoplasm occurring most frequently in the parotid gland. Exposure to radiation has been thought to play or...
Read more

Crohn's Disease

-
Image
Crohn's disease causes inflammation of the small intestine. Although it may involve any part of the digestive tract from the mouth to the anus, it most commonly affects the last part of the small intestine, called the ileum, and the large intestine, including the colon and rectum. This is considered a chronic condition because it may recur at various times throughout your lifetime, with periods of remission in which you are free of symptoms. There is no consistently accurate way to predict when a remission may occur or when symptoms will return. The disease may occur in people of all ages, although most are diagnosed before the age of 30. However, it also can affect young children and older people in their seventies or beyond. Crohn's disease occurs most commonly in people living in northern climates and affects men and women equally. The condition can be inherited and is common in some families. About 20 percent to 25 percent of those with Crohn's disease have a close r...
Read more